Biomet Grows Spinal Presence With Lanx Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Biomet said Lanx, which it is acquiring for $147 million, fills gaps in its spine device offerings and also complements the company’s geographical sales presence in the spine market.